FDA DEVICE FACTS
MC-Subtalar(TM) II
Merete Medical GmbH
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The MC-Subtalar™ II screw system is for the correction of flexible fla t feet in children (6 to < 12 years of age) and adolescence (12 to < 13 years of age). It is intended to block medial and plantar pronation of the talus, while, allowing normal subtalar joint motion. Specific indications for use include: Flexible flat feet in children and adolescence, Progression medial talus protrusion, Loss of longitudinal arch, Pain along the tibialis posterior, Age > 6 years, after conservative treatment did not result in a flat foot correction, Age < 13 years, while the deformity may be corrected manually.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。